Viatris

VTRSNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$21.795 B

$18.98 -1.27%

Close of 6 Nov 2026

As of 6 Nov 2026, Viatris (VTRS) has a market capitalization of $21.8B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$14.3B

#312 by revenue

Earnings

—

Not reported

Shares outstanding

1,146,454,729

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →

#22United TherapeuticsUTHR$24.1B
#23InsmedINSM$23.9B
#24ViatrisVTRS$21.8B
#25Alnylam PharmaceuticalsALNY$21.0B
#26Ascendis Pharma A/SASND$16.7B

What if Viatris were worth as much as…

Open the what-if tool →

Gold $28.2T

$24,583.93

Per share 1,296× higher

Bitcoin $1.53T

$1,330.19

Per share 70.1× higher

Apple $5.02T

$4,366.90

Per share 230× higher

Or at a round number

$50.0B $100.0B $200.0B $500.0B

Where these numbers come from

Share counts and financials for Viatris are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.